GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

GSK1349572 is an integrase inhibitor being developed for the treatment of human immunodeficiency virus -1 infection by ViiV Healthcare. This drug is experimental and has not been approved by the Food and Drug Administration (FDA).

Fosamprenavir is a drug in the protease inhibitor class that is approved by the FDA for the treatment of HIV infection.

Ritonavir is a drug in the protease inhibitor class that is approved by the FDA for the treatment of HIV infection.